Isabel Schwienbacher

Dr. Isabel Schwienbacher is a preclinical and clinical project manager at HMNC Brain Health.

Isabel has 15 years’ experience in pharmaceutical and biotech industries in discovery and development of pharmaceutical therapies for neurological and neuropsychiatric diseases along all stages, from target selection & validation over clinical candidate nomination to clinical Proof of Concept studies.

Her previous positions included leadership roles (laboratory personnel and scientists) with overall responsibility for preclinical in vivo drug discovery, development and repurposing projects in different CNS diseases. She is highly experienced in directing, monitoring and managing external studies at CROs and Universities.

At HMNC she covers scientific leadership, operational management and strategic planning of entire preclinical and clinical research and development programs of pharmaceutical compounds in conjunction with biomarkers for patient stratification.